2-(1H-Benzimidazol-2-yl)ethanamine CAS 29518-68-1: Your Trusted Pharmaceutical Intermediate Supplier in China

NINGBO INNO PHARMCHEM CO.,LTD. offers high-purity 2-(1H-Benzimidazol-2-yl)ethanamine (CAS 29518-68-1), a critical building block for API synthesis and fine chemical applications. Discover our reliable supply and competitive pricing for your manufacturing needs.

Get a Quote & Sample

Key Advantages of Partnering with Us

Uncompromising Quality Assurance

Our 2-(1H-Benzimidazol-2-yl)ethanamine meets stringent purity standards (≥99%), crucial for pharmaceutical applications. We ensure consistent quality, making us a preferred supplier for R&D and manufacturing.

Stable Supply Chain & Production

Leverage our robust manufacturing capabilities in China to ensure a stable and uninterrupted supply of this vital pharmaceutical intermediate. Purchase with confidence from a dedicated manufacturer.

Expert Technical Support

Benefit from our expertise in fine chemicals. We provide detailed product information and can assist you in sourcing the right quantity of 2-(1H-Benzimidazol-2-yl)ethanamine for your specific needs.

Versatile Applications in Pharmaceutical Synthesis

Active Pharmaceutical Ingredients (APIs)

Utilize 2-(1H-Benzimidazol-2-yl)ethanamine as a core building block in the synthesis of various APIs, ensuring high efficacy and desired pharmacological profiles. Buy this intermediate for your advanced drug development.

Fine Chemical Intermediates

This compound serves as a critical intermediate in the broader fine chemical industry, facilitating complex organic synthesis processes. Source your fine chemical needs from a reliable supplier.

Research & Development

Accelerate your R&D projects with readily available, high-purity 2-(1H-Benzimidazol-2-yl)ethanamine. Ideal for chemical research and developing novel compounds.

Custom Synthesis Projects

Engage with us for your custom synthesis requirements, leveraging our expertise in producing benzimidazole derivatives like 2-(1H-Benzimidazol-2-yl)ethanamine.